Artículos de revistas
A trypsin inhibitor from Peltophorum dubium seeds active against pest proteases and its effect on the survival of Anagasta kuehniella (Lepidoptera : Pyralidae)
Registro en:
Biochimica Et Biophysica Acta-general Subjects. Elsevier Science Bv, v. 1621, n. 2, n. 170, n. 182, 2003.
0304-4165
WOS:000182789100006
10.1016/S0304-4165(03)00055-2
Autor
Macedo, MLR
Freire, MDM
Cabrini, EC
Toyama, MH
Novello, JC
Marangoni, S
Institución
Resumen
A novel trypsin inhibitor was purified from the seeds of Peltophorum dubium (Spreng.). SDS-PAGE under reducing conditions showed that the inhibitor consisted of a single polypeptide chain (ca. 20 kDa). The dissociation constants of 4x10(-10) and 1.6x10(-10) M were obtained with bovine and porcine trypsin, respectively. This constant was lower (2.6x10(-7) M) for chymotrypsin. The inhibitory activity was stable over a wide range of temperature and pH and in the presence of DTT. The N-terminal sequence of the P. dubium inhibitor showed a high degree of homology with other Kunitz-type inhibitors. When fed to the insect Anagasta kuehniella, in an artificial diet (inhibitor concentration 1.6%), the inhibitor produced similar to56% and delayed the development of this lepidopteran. The concentration of inhibitor in the diet necessary to cause a 50% reduction in the weight (ED50) of fourth instar larvae was similar to1%. The action of the P dubium trypsin inhibitor (PDTI) on A. kuehniella may involve inhibition of the trypsin-like activity present in the larval midgut, resistance of the inhibitor to digestion by midgut enzymes and bovine trypsin, and association of the inhibitor with a chitin column and chitinous structures in the peritrophic membrane and/or midgut of the insect. (C) 2003 Elsevier Science B.V. All rights reserved. 1621 2 170 182
Materias
Ítems relacionados
Mostrando ítems relacionados por Título, autor o materia.
-
Multi-target-directed ligands for Alzheimer's disease: Discovery of chromone-based monoamine oxidase/cholinesterase inhibitors
Reis J.; Cagide F.; Valencia M.E.; Teixeira J.; Bagetta D.; Pérez C.; Uriarte E.; Oliveira P.J.; Ortuso F.; Alcaro S.; Rodríguez-Franco M.I.; Borges F. (Elsevier Masson SAS, 2018) -
SGLT-2 inhibitors for people with type 2 diabetes.
Autor desconocido (Elsevier, 2019)Evidence that sodium-glucose co-transporter-2 inhibitors (SGLT2i) can reduce cardiovascular risk—with trials showing reductions in cardiovascular death, myocardial infarction, and stroke—would suggest they have much to ... -
Environmental enrichment reverses tyrosine kinase inhibitor-mediated impairment through BDNF-TrkB pathway
Bengoetxea H.; Rico-Barrio I.; Ortuzar N.; Murueta-Goyena A.; Lafuente J.V. (Humana Press Inc., 2018)